A high genetic risk for MS, along with exposure to tobacco or other environmental factors, can affect early brain development ...

Blood storage conditions, age, and other factors can influence the levels of NfL, a nerve damage biomarker used in MS ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Columnist Desiree Lama has always known she wanted to help people; now she is achieving that goal through MS advocacy.

Tiziana's Phase 2 trial testing foralumab for nonactive secondary progressive multiple sclerosis (SPMS) has added six U.S.

Columnist Ben Hofmeister isn't as worried about his children inheriting MS as he is about them seeing the reality of living with the disease.

Vaccination didn't increase the risk of children or adolescents being diagnosed with pediatric MS within five years, a study ...

Children with MS from poorer families or other disadvantaged circumstances tend to have more inflammation and brain damage, a ...

MS patients undergoing hematopoietic stem cell transplant (HSCT) face physical and emotional challenges at each treatment ...

Hospitalization for severe COVID-19 more than doubles risk of MS, according to a study involving nearly 10 million people in ...

When faced with the obstacle course that is MS, columnist Ben Hofmeister remembers his strategy while in the Army Special Forces: Don't quit.

Roche will acquire Poseida Therapeutics, building on a partnership for CAR T-cell therapies in development for MS and other diseases.